Point of Service Patient Information
Adult myeloid leukaemias: current and future treatments - The Pharmaceutical Journal
Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial - Jädersten - Journal of Internal Medicine - Wiley Online Library
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom? | Haematologica
Chemotherapy | CancerQuest
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
PPT - Principles of Chemotherapy and Chemotherapy Complications PowerPoint Presentation - ID:9105192
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
Cytarabine Triphosphate - an overview | ScienceDirect Topics
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine | BMC Cancer | Full Text
Frontiers | Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
Genetic factors influencing cytarabine therapy | Pharmacogenomics
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
Adverse Cutaneous Reactions to Chemotherapy Agents - JDDonline - Journal of Drugs in Dermatology
Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence - ScienceDirect
Subcut Cytarabine (Ara-C) Shared Care and Community
7+3 (daunorubicin) for AML | ChemoExperts
Aracytidine, Ara-C Oligonucleotide Modification
Chemotherapeutic agents - YouTube
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears
Cytarabine | C9H13N3O5 - PubChem
Cytarabine (Cytarabine): Uses, Dosage, Side Effects, Interactions, Warning
